Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 Next Page Last Page
 
1
Aberrant Promoter Methylation in Serium DNA as a Biomarker ...
2005-05-01

... PROSTATE CANCER, UNITED STATES, GENES, RETINOIC ACIDS, CANCER SCREENING, SULFITES, STATISTICAL ANALYSIS, MORTALITY ...

DTIC Science & Technology

2
Role of TMS1 Silencing in the Resistance of Breast Cancer Cells to Apoptosis.
2004-01-01

Aberrant DNA methylation of promoter region CpG islands is associated with gene silencing and serves as an alternative to mutations in the inactivation of tumor suppressor genes in human cancers. Our lab has identified novel gene, TMS1, that is aberrantly...

National Technical Information Service (NTIS)

3
ABERRANT PROMOTER METHYLATION OF MULTIPLE GENES IN SPUTUM FROM INDIVIDUALS EXPOSED TO SMOKY COAL EMISSIONS

Aberrant methylation in the promoter region of cancer-related genes leads to gene transcriptional inactivation and plays an integral role in lung tumorigenesis. Recent studies demonstrated that promoter methylation was detected not only in lung tumors from patients with lung canc...

EPA Science Inventory

4
Aberrant Promoter Methylation in Serium DNA as a Biomarker ...
2005-05-01

... The main objective of this study is to develop a serum-based test for prostate cancer using DNA methylation of one or more candidate genes to ...

DTIC Science & Technology

5
Role of TMS1 Silencing in the Resistance of Breast Cancer Cells to Apoptosis.
2006-01-01

Aberrant DNA methylation of promoter region CpG islands is associated with gene silencing and serves as an alternative to mutations in the inactivation of tumor suppressor genes in human cancers. We identified a gene TMS1 (for Target of Methylation-mediat...

National Technical Information Service (NTIS)

6
Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer1
2004-07-01

AbstractThe maspin gene functions as a tumor suppressor in human breasts, and its expression is frequently lost during breast cancer progression. In vitro models of human breast cancer indicate that the loss of maspin expression is closely linked to aberrant methylation of the maspin promoter. We conducted a study on 30 archival ductal ...

PubMed Central

7
Transcriptional Repression as a Mechanism of BRCA-1 Inactivation.
2000-01-01

The basic hypothesis of this project is that aberrant cytosine methylation of the BRCA-1 CpG island promoter is a mechanism of BRCA-1 gene inactivation in sporadic human breast cancer. To test this hypothesis, archived frozen human breast cancer specimens...

National Technical Information Service (NTIS)

8
Nested methylation-specific polymerase chain reaction cancer detection method
2007-05-08

A molecular marker-based method for monitoring and detecting cancer in humans. Aberrant methylation of gene promoters is a marker for cancer risk in humans. A two-stage, or "nested" polymerase chain reaction method is disclosed for detecting methylated DNA sequences at sufficiently high levels of sensitivity to permit cancer screening ...

DOE Information Bridge

9
[CANCER RESEARCH 64, 2000�2006, March 15, 2004] Hypermethylation of the 5 CpG Island of the FHIT Gene Is Associated with

leukemia in Northern California. We measured DNA methylation in the promoter region of the FHIT gene in 190 of the FHIT gene, and methylation in this region correlates with loss of FHIT expression. To test whether aberrant methylation of the FHIT gene may play a role in pediatric leukemia, we ...

E-print Network

10
Microbiology (2000), 146, 669�676 Printed in Great Britain Fur-independent regulation of iron metabolism

RNA accumulation by iron was aberrant in a fur mutant strain, and Fur repressed an irr::lacZ promoter fusion in the presence of iron. Furthermore, metal- dependent binding of Fur to an irr gene promoter was demonstrated in the hemA promoter by Page et al. (1994). Therefore, regulation of hemA ...

E-print Network

11
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.
2011-02-28

Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this mechanism to contribute to tumor development depends on whether the genes affected are repressed because of their methylation. Many aberrantly methylated genes play important roles in development and are ...

PubMed

12
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer
2011-03-15

Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this mechanism to contribute to tumor development depends on whether the genes affected are repressed because of their methylation. Many aberrantly methylated genes play important roles in development and are ...

PubMed Central

13
NCI Funded Research Portfolio - Z01 BC 010669 Detail

We recently discovered that aberrant gene methylation occurs in the stroma and endothelium adjacent to tumor epithelium in prostate cancer patients. This suggests that epigenetic changes such as gene hypermethylation may play a role in the tumor microenvironment. These findings have implications for prostate cancer diagnosis and ...

Cancer.gov

14
Consistent DNA hypermethylation patterns in laryngeal papillomas.
2010-05-01

INTRODUCTION: This study examined the contribution of promoter hypermethylation to the pathogenesis of respiratory papillomatosis (RP), including recurrences (RRP) and progression to squamous cell carcinoma (SSC). MATERIALS AND METHODS: A retrospective cohort of 25 laryngeal papilloma cases included 21 RRP, two of which progressed to SCC. Aberrant ...

PubMed

15
Aberrant expression of the P2 promoter-specific transcript Runx1 in epiphyseal cartilage of Trps1-null mice.
2010-11-29

Tricho-rhino-phalangeal syndrome (TRPS) is an autosomal dominant skeletal disorder caused by mutations of the Trps1 gene, which encodes a GATA type transcriptional repressor. To investigate the genes that act downstream of Trps1, we performed a DNA array using ATDC5 cells. One of the target genes identified from the DNA array was ...

PubMed

16
Aberrant promoter methylation of multiple genes in sputum from individuals exposed to smoky coal emissions

SummaryAberrant methylation in the promoter region of cancer-related genes leads to gene transcriptional inactivation and plays an integral role in lung tumorigenesis. Recent studies demonstrated that promoter methylation was detected not only in lung tumors from patients with lung cancer but ...

PubMed Central

17
Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer
2009-03-23

BackgroundEpigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by promoter demethylation have been sporadically reported. We used an integrative method to analyze expression in primary head and neck squamous cell carcinoma (HNSCC) and pharmacologically demethylated cell lines to identify ...

PubMed Central

18
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
2011-01-31

The involvement of epigenetic aberrations in the development and progression of tumors is now well established. However, most studies have focused on the epigenetic inactivation of tumor suppressor genes during tumorigenesis and little is known about the epigenetic activation of cancer-associated genes, except for the DNA ...

PubMed Central

19
[Epigenetic inactivation of the RB1 gene as a factor of genomic instability: a possible contribution to etiology of chromosomal mosaicism during human embryo development].
2008-11-01

The methylation status of the cell cycle control gene RB1 has been studied in placental tissues of spontaneous abortions of the first trimester of pregnancy with mosaic variants of numerical chromosomal abnormalities verified by a molecular genetic examination. Aberrant methylation of the gene promoter region has ...

PubMed

20
Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation.
2011-02-12

The novel cancer/testis antigen gene, NY-SAR-35, is expressed exclusively in normal testis and in various histological types of tumor. However, the NY-SAR-35 gene expression is observed to be aberrant in several cancer cell lines and tissues. The analysis of methylation status of the NY-SAR-35 gene ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
21
Integrated genomic analyses of ovarian carcinoma.
2011-06-29

A catalogue of molecular aberrations that cause ovarian cancer is critical for developing and deploying therapies that will improve patients' lives. The Cancer Genome Atlas project has analysed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of ...

PubMed

22
Epigenetic regulation of Wnt signaling pathway in urological cancer.
2010-05-10

Constitutive activation of the Wnt signaling pathway is a common feature of solid tumors and contributes to uncontrolled cell-growth and impaired differentiation. We hypothesized that gene silencing mediated through aberrant promoter methylation of upstream Wnt antagonist genes might result in beta-catenin ...

PubMed

23
Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
2010-03-24

BackgroundWnt inhibitory factor-1(WIF-1) acts as a Wnt-antagonists and tumor suppressor, but hypermethylation of WIF-1 gene promoter and low expression activate Wnt signaling aberrantly and induce the development of various human tumors. With this work we intended to investigate the expression and promoter ...

PubMed Central

24
Surfactant protein DNA methylation: A new entrant in the field of lung cancer diagnostics? (Review)
2009-01-01

Lung cancer is a major cause of cancer-related mortality in both men and women. A 5-year survival of lung cancer patients is only 15% with a negative correlation between progressively advanced lung cancer stage and a 5-year survival period. The only chance for cure is surgical resection if done at the early stage of the disease. Therefore, an early diagnosis and a better prediction of prognosis ...

PubMed Central

25
Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls
2007-02-26

IntroductionFemale germline BRCA gene mutation carriers are at increased risk for developing breast cancer. The purpose of our study was to establish whether healthy BRCA mutation carriers demonstrate an increased frequency of aberrant gene promoter hypermethylation in ductal lavage (DL) fluid, compared with ...

PubMed Central

26
Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
2002-02-01

The aberrant methylation of cytosine residues in the promoter region of growth regulatory genes is now widely recognized as an additional mechanism for gene inactivation in cancer cells. In this study we analyzed the methylation status of four growth regulatory genes (p16, RASSF1A, cyclinD2, ...

PubMed Central

27
Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
2009-11-01

Recent studies have shown that promoter hypermethylation of tumor suppressor genes is an important factor in carcinogenesis of several human organs. The purpose of this study was to examine the methylation status of CHFR, a novel cell cycle regulatory gene, in both primary oral cancer tumors and the adjacent normal mucosa, and to ...

PubMed

28
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
2010-11-01

Alternative splicing of mRNA precursors is a nearly ubiquitous and extremely flexible point of gene control in humans. It provides cells with the opportunity to create protein isoforms of differing, even opposing, functions from a single gene. Cancer cells often take advantage of this flexibility to produce proteins that promote growth ...

PubMed Central

29
Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer.
2010-03-19

Runx3 and CHFR genes were defined as tumor suppressor genes in gastric cancer (GC) recently. This paper was to investigate the roles of methylation and expression status of Runx3 and CHFR genes in GC patients. Methylation-specific polymerase chain reaction (MSP) and bisulfite DNA sequencing (BSP) were used to detect methylation status ...

PubMed

30
The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.
2004-12-16

Several epidemiological studies on ataxia-telangiectasia families indicate that obligate ATM heterozygotes display an elevated risk for developing breast cancer. However, a molecular basis for a potential link between diminished ATM function and sporadic breast malignancy remains elusive. Here, we show that 78% (18 out of a panel of 23) of surgically removed breast tumors (stage II or greater) ...

PubMed

31
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype
2008-10-07

Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter occurs in about 40% of breast tumours and has been correlated with reduced APC protein levels. To what extent epigenetic alterations of the APC gene may differ according to specific breast cancer phenotypes, remains to be elucidated. Our aim ...

PubMed Central

32
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
2009-04-26

Chromosomal translocations involving the ERG locus are frequent events observed in human prostate cancer pathogenesis, however the biologic role of ERG aberrant expression is controversial.1 Here we demonstrate that the aberrant expression of ERG is a progression event in prostate tumorigenesis. We find that prostate cancer specimens containing the ...

PubMed Central

33
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
2010-09-03

Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation ...

PubMed Central

34
[Diagnostics for epigenetic pathology in hereditary and oncologic diseases].

The review considers the epigenetic defects and their diagnostics in several hereditary disorders and tumors. Aberrant methylation of the promoter or regulatory region of a gene results in its functional inactivation, which is phenotypically similar to structural deletion. Screening tests were developed for Prader-Willi, Angelman, ...

PubMed

35
Methylation destiny: Moira takes account of histones and RNA polymerase II.
2010-02-27

Aberrant DNA methylation is deeply involved in various human disorders. Contrary to our initial expectation, aberrant methylation is now known to possess several unique characteristics different from mutations, including target gene specificity. Specific cancers have methylation of specific genes and specific ...

PubMed

36
Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target.
2011-06-09

Endometriosis, a common, benign, estrogen-dependent disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue that is found primarily in the peritoneum, ovaries and rectovaginal septum. Recently, endometriosis has been alternatively described as an immune disease, a genetic disease and a disease caused by exposure to environmental factors, ...

PubMed

37
Transposon-induced promoter scrambling: A mechanism for the evolution of new alleles
1995-03-14

We have studied a germinal revertant of the Mutator (Mu3)-induced mutation (Adhl-3F1124) of the maize alcohol dehydrogenase 1 gene (adh1). Transposon Mu3 was inserted at the TATA box of the promoter. The excision of Mu3 caused a complex, multibreakpoint DNA rearrangement with deletion, inverted duplication, and inversions affecting 430 nucleotides in the ...

Energy Citations Database

38
Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product
1991-09-01

The aberrant overexpression of interleukin 6 (IL-6) is implicated as an autocrine mechanism in the enhanced proliferation of the neoplastic cell elements in various B- and T-cell malignancies and in some carcinomas and sarcomas; many of these neoplasms have been shown to be associated with a mutated p53 gene. The possibility that wild-type (wt) p53, a ...

Energy Citations Database

39
Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
2011-06-10

BackgroundLong-term gene silencing throughout cell division is generally achieved by DNA methylation and other epigenetic processes. Aberrant DNA methylation is now widely recognized to be associated with cancer and other human diseases. Here we addressed the contribution of the multifunctional nuclear factor CTCF to the epigenetic regulation of the human ...

PubMed Central

40
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.
2006-06-21

The synucleinopathies are neurodegenerative disorders defined by inclusions composed of aberrantly fibrillized alpha-synuclein, but factors contributing to this process remain largely unknown. The authors examined the glucocerebrosidase gene in 75 autopsy specimens with different synucleinopathies and identified mutations in 23% of cases of dementia with ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
41
Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.
2010-09-20

DNA methylation patterns are frequently dysregulated in cancer, although little is known of the mechanisms through which specific gene sets become aberrantly methylated. The ecotropic viral integration site 1 (EVI1) locus encodes a DNA binding zinc-finger transcription factor that is aberrantly expressed in a subset of acute myeloid ...

PubMed

42
Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer
2011-04-01

Human cancer cells frequently have regions of their DNA hypermethylated, which results in transcriptional silencing of affected genes and promotion of tumor formation. However, it is still unknown whether cancer-associated aberrant DNA methylation is targeted to specific genomic regions, whether this methylation also occurs in ...

PubMed Central

43
Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
2011-07-14

Epigenetic events have emerged as key mechanisms in the regulation of critical biological processes and in the development of a wide variety of human malignancies, including gastric cancer (GC), however precise gene targets of aberrant DNA methylation in GC remain largely unknown. Here, we have combined pyrosequencing-based quantitative analysis of DNA ...

PubMed

44
Rac1b recruits Dishevelled and ?-catenin to Wnt target gene promoters independent of Wnt3A stimulation.
2011-06-06

We previously reported a functional interaction between aberrant Wnt signaling and Rac1/Rac1b GTPases in tumorigenesis. In this study, we further investigated the mechanistic role of nuclear Rac1b. Using chromatin immunoprecipitation (ChIP) studies, we show that Rac1b resides at the promoters of Wnt target genes, c-Myc and Cyclin D1, ...

PubMed

45
Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma
2008-08-28

AIM: To investigate the aberrant methylation of CHFR promoter in human gastric cancer (GC) and its impact on the expression of CHFR mRNA and protein, as well as its correlation with clinical and histological features of human GC.METHODS: Methylation-specific polymerase chain reaction (MSPCR) was used to detect the methylation status of CHFR ...

PubMed Central

46
Epigenetic silencing of RELN in gastric cancer.
2010-01-01

RELN (Reelin) is an extracellular glycoprotein that plays a critical role in neuronal migration. Here we show that the RELN gene is frequently silenced in gastric cancers (GCs) by aberrant promoter hypermethylation. Although RELN was strongly expressed in non-tumor gastric epithelia, its expression was weak, or absent, in GC cell lines ...

PubMed

47
Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
2010-02-01

Aberrant methylation of promoter CpG islands is associated with transcriptional inactivation of tumor-suppressor genes in cancer. TFPI2, a Kunitz-type serine proteinase inhibitor, has been identified as a putative tumor-suppressor gene from genome-wide screening for aberrant methylation, using ...

PubMed

48
Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
2011-08-25

The aberrant methylation of promoter CpG islands is known to be a major inactivation mechanism of tumor-related genes, which plays a crucial role in the progression of silencing in human cancers including hepatocellular carcinoma (HCC). Thus, we sought to examine the promoter methylation status of five important ...

PubMed

49
Gene Promoter Hypermethylation in Tumors and Plasma of Breast Cancer Patients
2005-08-31

PurposeTo measure the hypermethylation of four genes in primary tumors and paired plasma samples to determine the feasibility of gene promoter hypermethylation markers for detecting breast cancer in the plasma.Materials and MethodsDNA was extracted from the tumor tissues and peripheral blood plasma of 34 patients with invasive breast ...

PubMed Central

First Page Previous Page 1 2 3 Next Page Last Page